LAYERMUNE® SE

COMPOSITION

LAYERMUNE® SE is an inactivated bacterial vaccine (bacterin) that contains multiple selected strains of Salmonella Enteritidis (SE) to aid in the prevention of SE infection of internal organs and colonization of the intestinal tract.

 

INDICATIONS

LAYERMUNE® SE is indicated for the use in breeding and laying chickens at least 12 weeks of age to aid in the control of disease caused by SE.
LAYERMUNE® SE aids in the reduction of colonization by SE strains of: the internal organs, including the reproductive tract, the ovary and consequently the egg contents in the intestinal tract thereby reducing salmonella shed in the environment and egg shell contamination.
LAYERMUNE® SE has proven efficacy against all SE phage types including the highly invasive phage type 4.

 

ADMINISTRATION AND DOSAGE

LAYERMUNE® SE is administrated to chickens by the subcutaneous route under the skin on the back of the neck. The dose is 0.5 ml  per bird.

 

 

STORAGE

Store vaccine between +2°C and +8°C or 35°F and 45°F. Protect from light. Do not freeze.

PACKAGED

1,000 doses in each 500ml bottle.

MULTIMUNE K5™

COMPOSITION

MULTIMUNE K5™ Contains five inactivated isolates of Pasteurella multocida including serotypes 1, 3, and 4, and 2 isolates of 3x4.  These isolates are typical of field strains that cause fowl cholera and were selected for their ability to stimulate strong, long-lasting immunity against fowl cholera infection in turkeys and chickens.  Because the organisms incorporated in MULTIMUNE K5 are inactivated, there is no risk that the antigens may revert to virulence or otherwise initiate vaccine-induced fowl cholera.  The bacterin is emulsified in an oil adjuvant.

INDICATIONS

MULTIMUNE K5 is recommended for use in healthy turkeys at least 18 weeks of age and chickens at least 12 weeks of age to help prevent fowl cholera caused by Pasteurella multocida infection.

ADMINISTRATION

For ease of administration and to prevent shock, Multimune K5 should be warmed to room temperature.  Subcutaneously administer 0.5 ml in the lower neck region of turkeys and chicks in a direction away from the head and parallel with the neck.  In turkeys, inject in the feathered area of the neck.  Do not inject into muscle or neck vertebrae.  For best results, give initial vaccination to chickens at least 12 weeks old and turkeys at least 18 weeks old and re-vaccinate at least three to four weeks later.  Turkeys may be re-vaccinated at three-four month intervals.

 

STORAGE

Store vaccine between +2°C and +8°C or 35°F and 45°F. Protect from light. Do not freeze

PACKAGED

1,000 doses in each 500 ml bottle 

REOMUNE® 3

Inactivated vaccine, proprietary adjuvant. For the immunisation of chickens against Reovirus Diseases (3 strains).

COMPOSITION

REOMUNE® 3 is an inactivated vaccine containing three avian reoviruses including strain S1133 (Tenosynovitis pathotype), strain 2408 (Malabsorption syndrome pathotype) and strain SS412 (Distinct serotype from the S1133 standard-type reoviruses).
Reovirus SS412 is a causative agent of proventriculitis and malabsorption syndrome in broilers. The viruses contained in REOMUNE®3 are non-cloned isolates. The adjuvant is a proprietary formulation that provides uniformly high serological titers of maximum duration.

INDICATIONS

REOMUNE® 3 is indicated to aid in the prevention of disease caused by avian reoviruses of the classical S1133 and 2408 serotypes and the variant serotype SS412. Breeder vaccination provides maternal antibodies to progeny to aid in the prevention of Tenosynovitis (viral arthritis) and the Malabsorption syndrome including feed passage, brittle bone and proventriculitis.
A prime with live tenosynovitis (reovirus) vaccine is recommended at least four weeks in advance of administration of REOMUNE® 3. . REOMUNE 4 should be administered to layer and breeder-type pullets 3 to 4 weeks before the onset of lay, between 16 and 20 weeks of age. The vaccine must be injected subcutaneously (under the skin of the neck)  at the dose of 0.5 ml per bird.

STORAGE

Store vaccine between +2°C and +8°C or 35°F and 45°F. Protect from light. Do not freeze.

PACKAGED

1,000 doses in each 500 ml bottle.

REPROMUNE 4™

COMPOSITION

REPROMUNE 4™ is an inactivated oil emulsion vaccine containing infectious Bursal Disease virus Luckert strain, Newcastle Disease virus La Sota strain, Infectious Bronchitis viruses (Holland and Mass M41 strains) and two reo virus strains: S1133 (Tenosynovitis pathotype) and strain 2408 (Malabsorption pathotype).

INDICATIONS

The vaccine is indicated for use in healthy breeder replacement chickens and breeder hens as an aid in the prevention of diseases caused by Infectious Bursal Disease virus, Newcastle Disease virus, Infectious Bronchitis virus and reo virus. Breeder vaccination provides maternal antibody to progeny of breeder hens as an aid in the prevention of Bursal Disease, Tenosynovitics (viral arthritis) and Malabsorption syndrome.Optimum results with REPROMUNE 4 require that chickens are adequately primed with live Infectious Bursal Disease vaccine, Tenosynovitis vaccine and Bronchitis vaccine of the Mass type at least four weeks in advance of administration of the inactivated vaccine.  REPROMUNE 4 should be administered to layer and breeder-type pullets 3 to 4 weeks before the onset of lay, between 16 and 20 weeks of age. The vaccine must be injected subcutaneously (under the skin of the neck)  at the dose of 0.5 ml per bird.

ADMINISTRATION AND DOSAGE

The vaccine must be injected: subcutaneously (under the skin of the neck)/ intramuscular (breast ) at the dose of 0,5ml per bird.CEVAC® CORYMUNE 7K should be administered to breeder and laying-type pullets, 2 to 4 weeks before the onset of the lay, between 14 and 18 weeks of age.

STORAGE

Store vaccine between +2°C and +8°C or 35°F and 45°F.Protect from light. Do not freeze.

PACKAGED

1,000 doses (500 ml bottle).

CEVAC® CORYMUNE 7K

COMPOSITION

CEVAC® CORYMUNE 7K contains an inactivated combination of Avibacterium paragallinarum serotypes A, B and C, and Salmonella Enteritidis strain, La Sota strain of Newcastle Disease virus, Massachussetts strain of the Infectious Bronchitis virus and B8/78 strain of the EDS virus, homogenized with oil adjuvant and thiomersal as a preservative.

INDICATIONS

CEVAC® CORYMUNE 7K is recommended for the active immunization of breeder and laying-type chicken flocks against Infectious Coryza caused by Avibacterium paragallinarum, Salmonella Enteritidis Infection, Newcastle Disease, Infectious Bronchitis and Egg Drop Syndrome’76.The birds should be previously immunised with live vaccines against Newcastle Disease and Infectious Bronchitis and 4 to 6 weeks before, with an inactivated vaccine against Infectious Coryza and Salmonella Enteritidis Infection.

ADMINISTRATION AND DOSAGE

The vaccine must be injected: subcutaneously (under the skin of the neck)/ intramuscular (breast ) at the dose of 0,5ml per bird.CEVAC® CORYMUNE 7K should be administered to breeder and laying-type pullets, 2 to 4 weeks before the onset of the lay, between 14 and 18 weeks of age.

STORAGE

Store vaccine between +2°C and +8°C or 35°F and 45°F. Protect from light. Do not freeze.

PACKAGED

1,000 dose bottle.

Loading...